Annals of Palliative Medicine earns its first official impact factor

Annals of Palliative Medicine earns its first official impact factor

Charles B. Simone II

New York Proton Center, New York, NY, USA

Correspondence to: Charles B. Simone II, MD. New York Proton Center, 225 East 126th Street, New York, NY 10035, USA. Email:

Submitted Jun 30, 2019. Accepted for publication Jul 02, 2018.

doi: 10.21037/apm.2019.07.03

On June 20, 2019, we learned that Annals of Palliative Medicine has obtained its first official impact factor (IF) for the 2018 citation year. The IF, as published in the annual Journal Citation Reports (JCR), is 1.262. This news is on the heels of the January 2019 announcement from Clarivate Analytics that Annals of Palliative Medicine met the high bar for inclusion and became indexed in Science Citation Index Expanded (SCIE) (1).

Annals of Palliative Medicine is an open-access, international, peer-reviewed journal that provides up-to-date information and professional support for health care providers in palliative medicine disciplines to improve the quality of life for patients and their families and caregivers (2). Annals of Palliative Medicine became indexed in PubMed in early 2015 (3) and had articles published beginning in 2016 included in the Emerging Sources Citation Index (ESCI) (4).

The obtainment of an official IF is a testament to the high quality of Annals of Palliative Medicine and the esteem for which the journal is regarded by the international palliative care community. Today, Annals of Palliative Medicine is considered a premier journal for original research and review articles in palliative oncology and palliative medicine.

The impactor factor is a calculation determined based on the number of citations accumulated in 2018 for manuscripts published in 2016 and 2017. In honor and appreciation for the quality submissions that contributed to the 2018 IF, the most cited articles from 2016 to 2017 are highlighted below:

1) Cheon S, Agarwal A, Popovic M, et al. The accuracy of clinicians’ predictions of survival in advanced cancer: a review. Ann Palliat Med 2016;5:22-9.

2tied) Bedard G, McDonald R, Poon I, et al. Stereotactic body radiation therapy for non-spine bone metastases--a review of the literature. Ann Palliat Med 2016;5:58-66.

2tied) Chow R, Bruera E, Chiu L, et al. Enteral and parenteral nutrition in cancer patients: a systematic review and meta-analysis. Ann Palliat Med 2016;5:30-41.

4) Cotogni P. Enteral versus parenteral nutrition in cancer patients: evidences and controversies. Ann Palliat Med 2016;5:42-9.

5) Brugnoli MP. Clinical hypnosis for palliative care in severe chronic diseases: a review and the procedures for relieving physical, psychological and spiritual symptoms. Ann Palliat Med 2016;5:280-97.

6tied) Blake A, Wan BA, Malek L, et al. A selective review of medical cannabis in cancer pain management. Ann Palliat Med 2017;6:S215-22.

6tied) Olagunju AT, Sarimiye FO, Olagunju TO, et al. Child's symptom burden and depressive symptoms among caregivers of children with cancers: an argument for early integration of pediatric palliative care. Ann Palliat Med 2016;5:157-65.

8tied) Chow R, Hoskin P, Hollenberg D, et al. Efficacy of single fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review and meta-analysis. Ann Palliat Med 2017;6:125-42.

8tied) Riffin C, Kenien C, Ghesquiere A, et al. Community-based participatory research: understanding a promising approach to addressing knowledge gaps in palliative care. Ann Palliat Med 2016;5:218-24.

8tied) Wei R, Simone CB 2nd, Lutz S. Society for palliative radiation oncology: founding, vision, and report from the Second Annual Meeting. Ann Palliat Med 2016;5:74-5.

8tied) Chiu N, Chiu L, Popovic M, et al. Latest advances in the management of radiation-induced pain flare, nausea and vomiting. Ann Palliat Med 2016;5:50-7.

8tied) Chow R, Tsao M, Pulenzas N, et al. Do patients with brain metastases selected for whole brain radiotherapy have worse baseline quality of life as compared to those for radiosurgery or neurosurgery (with or without whole brain radiotherapy)? Ann Palliat Med 2016;5:1-12.

Furthermore, Annals of Palliative Medicine would like to acknowledge its most cited articles of all time since the journal founding in 2012:

1) Davis MP, Temel JS, Balboni T, et al. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med 2015;4:99-121.

2) Hui D, Bruera E. Models of integration of oncology and palliative care. Ann Palliat Med 2015;4:89-98.

3) Schug SA, Goddard C. Recent advances in the pharmacological management of acute and chronic pain. Ann Palliat Med 2014;3:263-75.

4tied) Woo A, Lechner B, Fu T, et al. Cut points for mild, moderate, and severe pain among cancer and non-cancer patients: a literature review. Ann Palliat Med 2015;4:176-83.

4tied) Ferrell B, Malloy P, Virani R. The End of Life Nursing Education Nursing Consortium project. Ann Palliat Med 2015;4:61-9.

4tied) Johnstone C, Lutz ST. The role of hypofractionated radiation in the management of non-osseous metastatic or uncontrolled local cancer. Ann Palliat Med 2014;3:291-303.

7tied) Jones JA, Simone CB 2nd. Palliative radiotherapy for advanced malignancies in a changing oncologic landscape: guiding principles and practice implementation. Ann Palliat Med 2014;3:192-202.

7tied) Richardson P. Spirituality, religion and palliative care. Ann Palliat Med 2014;3:150-9.

9) Smith HS, Smith JM, Seidner P. Opioid-induced nausea and vomiting. Ann Palliat Med 2012;1:121-9.

10tied) Zhi WI, Smith TJ. Early integration of palliative care into oncology: evidence, challenges and barriers. Ann Palliat Med 2015;4:122-31.

10tied) Simone CB 2nd, Jones JA. Palliative care for patients with locally advanced and metastatic non-small cell lung cancer. Ann Palliat Med 2013;2:178-88.

10tied) Aggarwal C. Targeted therapy for lung cancer: present and future. Ann Palliat Med 2014;3:229-35.

The IF of Annals of Palliative Medicine is certain to rise significantly in the coming years. The journal more than doubled the number of times its articles were cited from 2016 to 2017, and it again double the citation number from 2017 to 2018, already ensuring a rise for 2019. Additionally, the journal has become increasingly selective in its article acceptance rate, and several impactful focused issues are planned for the remainder of 2019 and beyond, further ensuring the IF will continue to rise in 2020 and beyond.

With the exciting news of our first official IF, we would like to extend our heartfelt gratitude to all of our Editorial Board Members, Guest Editors, authors, and reviewers for their significant contributions. We also thank our readers for choosing Annals of Palliative Medicine as your source of novel, clinically meaningful, and high-impact palliative medicine content.

More news about this announcement is available on the Annals of Palliative Medicine website at




Conflicts of Interest: The author has no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.


  1. Simone CB 2nd. Annals of Palliative Medicine is now indexed in Science Citation Index Expanded (SCIE). Ann Palliat Med 2019;8:102-3. [Crossref] [PubMed]
  2. Simone CB 2nd. Current focus and future advances for Annals of Palliative Medicine. Ann Palliat Med 2014;3:37-8. [PubMed]
  3. Simone CB 2nd. Annals of Palliative Medicine is indexed in PubMed. Ann Palliat Med 2015;4:46-7. [PubMed]
  4. Simone CB 2nd. Annals of Palliative Medicine has become indexed in Emerging Sources Citation Index Web of Science and Scopus. Ann Palliat Med 2016;5:325-6. [Crossref] [PubMed]
Cite this article as: Simone CB 2nd. Annals of Palliative Medicine earns its first official impact factor. Ann Palliat Med 2019;8(3):352-354. doi: 10.21037/apm.2019.07.03